Skip to main content
. 2014 Mar 13;306(9):G779–G787. doi: 10.1152/ajpgi.00183.2013

Fig. 6.

Fig. 6.

PCM attenuates C. sakasakii-triggered nuclear translocation of NF-κB-P65 in fetal human intestinal H4 cells. A: treated H4 cells were processed for immunolabeling with antibody against NF-κB p65 (total) (red). Nuclei were indicated with DAPI staining (blue). B: quantitation of cells for nuclear translocation of NF-κB-p65. The percentage of cells with nuclear translocation of NF-κB-p65 was calculated and graphed (n = 110 cells in the C. sakazakii-treated group, n = 119 cells in the PCM plus C. sakazakii-treated group, 2-sided χ2 with Yates correction, χ2 = 38.19, P < 0.05).